Akari Therapeutics (AKTX) executive compensation, 2026 proxy

Abizer Gaslightwala, President and Chief Executive Officer, was paid $1.7M in 2025.

Filed
June 4, 2026
Annual meeting
June 30, 2026
Pay year
2025
Named executives
4
CEO total pay
$1.7M2025
CEO option awards
$1,332,542Largest CEO compensation component
Farag stock awards
$48,609Interim CFO equity compensation
Hombeck other compensation
$24,443Included unused vacation payout
CEO target bonus
50% of base salaryGaslightwala employment agreement
Hombeck target bonus
100% of base salaryFormer CFO employment agreement

How Gaslightwala was paid

$1.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary20%Option awards80%

Named executive officers

ExecutiveTotal
Abizer GaslightwalaPresident and Chief Executive Officer$1,663,603
Kameel FaragInterim Chief Financial Officer$117,435
Samir R. PatelFormer President and Chief Executive Officer$324,985
Torsten HombeckFormer Interim Chief Financial Officer$621,955

What changed and why

  • $1.7M$1,663,603 was CEO Abizer Gaslightwala’s total 2025 compensation, including $1,332,542 in option awards.
  • $331K$331,061 was Gaslightwala’s 2025 salary after becoming CEO in April 2025.
  • $117K$117,435 was Interim CFO Kameel Farag’s total 2025 compensation, including a $25,000 bonus and $48,609 in stock awards.
  • $325K$324,985 was former CEO Samir Patel’s total 2025 compensation, entirely from option awards.
  • $622K$621,955 was former CFO Torsten Hombeck’s total 2025 compensation, including $24,443 in other compensation.
  • 2025 annual performance bonuses had not yet been determined when the proxy was prepared.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.